XML 64 R49.htm IDEA: XBRL DOCUMENT v3.25.1

Business Segments (Tables)

12 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Information about our Operating and Reportable Segments

The tables below summarize information about our operating and reportable segments.

			Year Ended March 31, 2025
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	960,010					$	177,752											$	1,137,762
Cost of sales			428,871						74,428												503,299
Gross profit			531,139						103,324												634,463
Advertising and marketing			129,431						26,292												155,723
Contribution margin			$	401,708					$	77,032											478,740
Other operating expenses**																					141,965
Operating income																					$	336,775

*Intersegment revenues of $3.9 million were eliminated from the North American OTC Healthcare segment.

**Other operating expenses for the year ended March 31, 2025 includes a tradename impairment charge of $12.5 million.

			Year Ended March 31, 2024
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	958,260					$	167,097											$	1,125,357
Cost of sales			429,361						71,548												500,909
Gross profit			528,899						95,549												624,448
Advertising and marketing			131,494						21,821												153,315
Contribution margin			$	397,405					$	73,728											471,133
Other operating expenses																					128,704
Operating income																					$	342,429

* Intersegment revenues of $3.7 million were eliminated from the North American OTC Healthcare segment.

			Year Ended March 31, 2023
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	973,774					$	153,951											$	1,127,725
Cost of sales			441,844						60,587												502,431
Gross profit			531,930						93,364												625,294
Advertising and marketing			123,926						21,135												145,061
Contribution margin			$	408,004					$	72,229											480,233
Other operating expenses**																					502,648
Operating loss																					$	(22,415)

*Intersegment revenues of $4.3 million were eliminated from the North American OTC Healthcare segment.

**Other operating expenses for the year ended March 31, 2023 includes a tradename impairment charge of $321.4 million and a goodwill impairment charge of $48.8 million.

Schedule of Information about our Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.

			Year Ended March 31, 2025
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	112,173					$	5,524											$	117,697
Cough & Cold			82,533						23,681												106,214
Women's Health			216,335						20,496												236,831
Gastrointestinal			174,891						81,052												255,943
Eye & Ear Care			158,858						24,464												183,322
Dermatologicals			120,770						8,177												128,947
Oral Care			81,868						13,162												95,030
Other OTC			12,582						1,196												13,778
Total segment revenues			$	960,010					$	177,752											$	1,137,762

			Year Ended March 31, 2024
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	111,996					$	5,455											$	117,451
Cough & Cold			93,575						25,445												119,020
Women's Health			217,103						23,318												240,421
Gastrointestinal			160,889						70,721												231,610
Eye & Ear Care			156,553						22,870												179,423
Dermatologicals			123,288						5,814												129,102
Oral Care			83,212						13,093												96,305
Other OTC			11,644						381												12,025
Total segment revenues			$	958,260					$	167,097											$	1,125,357

			Year Ended March 31, 2023
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	116,582					$	2,680											$	119,262
Cough & Cold			100,218						26,770												126,988
Women's Health			231,754						19,597												251,351
Gastrointestinal			156,957						69,626												226,583
Eye & Ear Care			151,879						19,197												171,076
Dermatologicals			119,822						3,919												123,741
Oral Care			85,542						12,085												97,627
Other OTC			11,020						77												11,097
Total segment revenues			$	973,774					$	153,951											$	1,127,725

Schedule of Segment Revenue by Geographic Area

Our total segment revenues by geographic area are as follows:

			Year Ended March 31,
			2025						2024						2023
United States			$	897,540					$	886,470					$	953,222
Rest of world			240,222						238,887						174,503
Total			$	1,137,762					$	1,125,357					$	1,127,725

Schedule of Allocation of Long-Term Assets to Segments

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:

March 31, 2025 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	498,936					$	28,489											$	527,425
Intangible assets
Indefinite-lived			2,068,752						68,234												2,136,986
Finite-lived			141,234						17,130												158,364
Intangible assets, net			2,209,986						85,364												2,295,350
Total			$	2,708,922					$	113,853											$	2,822,775

March 31, 2024 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	498,936					$	28,797											$	527,733
Intangible assets
Indefinite-lived			2,092,853						74,309												2,167,162
Finite-lived			135,932						17,489												153,421
Intangible assets, net			2,228,785						91,798												2,320,583
Total			$	2,727,721					$	120,595											$	2,848,316

Schedule of Goodwill and Intangible Assets by Geographic Areas

Our goodwill and intangible assets by geographic area are as follows:

			Year Ended March 31,
			2025						2024
United States			$	2,708,922					$	2,727,721
Rest of world			113,853						120,595
Total			$	2,822,775					$	2,848,316

X

- Definition

[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]

+ References

No definition available.

+ Details

Name:	pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock
Namespace Prefix:	pbh_
Data Type:	dtr-types1:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration